Tyson Kim

Amministratore Delegato presso SYNTEKABIO, INC.

Technology Services

Health Technology

Posizioni attive di Tyson Kim

Società	Posizione	Inizio	Fine
SYNTEKABIO, INC.	Amministratore Delegato	01/01/2015	-
Radexel Co. Ltd. Radexel Co. Ltd. Medical SpecialtiesHealth Technology Radexel Co. Ltd. is a medical technology company based in Seoul, KR. The company was founded in 2018 by CEO Tyson Kim on the basis of Seoul Asan Medical Center development technology. Radexel is developing a radiation therapy device that treats cancer precisely with the world's first developed magnetic-radiation fusion technology and AI treatment plan. The device reduces side effects of normal tissue adjacent to cancer and improves treatment effect. It is also low-cost and compact, and can be installed in the same space as the existing radiation therapy device.	Amministratore Delegato	-	-

Distribuzione geografica

Stati Uniti	2
Corea del Sud	2

Posizioni

Chief Executive Officer

Settori

Technology Services	2
Health Technology	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
SYNTEKABIO, INC.	Technology Services

Aziende private	1
Radexel Co. Ltd. Radexel Co. Ltd. Medical SpecialtiesHealth Technology Radexel Co. Ltd. is a medical technology company based in Seoul, KR. The company was founded in 2018 by CEO Tyson Kim on the basis of Seoul Asan Medical Center development technology. Radexel is developing a radiation therapy device that treats cancer precisely with the world's first developed magnetic-radiation fusion technology and AI treatment plan. The device reduces side effects of normal tissue adjacent to cancer and improves treatment effect. It is also low-cost and compact, and can be installed in the same space as the existing radiation therapy device.	Health Technology

Aziende private

Health Technology